Drug intelligence / Profile preview

Curasept Prevent Probiotic

Development stage
Unknown
Lead developer
Curasept
Modality
Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Curasept Prevent Probiotic is a dietary supplement developed by Curasept S.p.A. designed to support oral health by promoting eubiosis within the oral microbiome. It is formulated with specific probiotic strains, including *Bifidobacterium lactis* HN019 and *Kluyveromyces marxianus fragilis* B0399, along with supportive ingredients such as biotin and colostrum. The product is intended to prevent and manage periodontal diseases, including Stage I and II periodontitis, by balancing the bacterial flora and supporting the local immune response. In clinical research led by Massimo Corsalini, it is evaluated as part of a comprehensive oral hygiene regimen that includes ozonized olive oil-based toothpaste and mouthwash to improve clinical periodontal parameters.

Brand names
Curasept Prevent ProbioticCurasept Prevent Probiotico
Other names
Curasept Prevent Probiotico Integratore Alimentare

Beyond the preview

Go deeper on Curasept Prevent Probiotic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curasept Prevent Probiotic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call